Harshabad Singh, Program Director Hepatobiliary and Pancreas Cancers at Mass general Brigham, shared on LinkedIn:
“Tonight we celebrated the successful completion of Daraxonrasib expanded access program (EAP) at Mass General Brigham.
Since July we treated over 50 patients on the EAP. One of the most gratifying experiences of my professional journey.
Huge shout out to our amazing team especially Mary Linton Peters who led efforts for us. CRCs, Research Nurses, regulatory teams, pharmacy, our pancreatic cancer docs all worked over time to ensure patients got rapid access!
Grateful for tremendous support from Shannon Himber, Matthew Frigault, Becca Heist, Justin Gainor, David Ryan.
Tagging our team here Doris Stocker, Andrea Hansen. Jeffrey Clark, Lindor Qunaj, John Yang.”
You can also read:
- Anirban Maitra: New Insights Into Targeted Therapy Sensitivity in Pancreatic Cancer
- Ron DePinho: Advancing Pancreatic Cancer Interception Through RAS Targeting
- PRECEDE Study: Pancreatic Imaging Findings During Surveillance in BRCA1, BRCA2, ATM, and PALB2 Heterozygotes
